Clinical Trial

A Confirmatory Trial of Multidisciplinary Digital Therapeutics for Patellofemoral Pain Syndrome

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 23, 2025 (before its estimated March 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled confirmatory study will be evaluating an mobile application, MORA Cure (ETH-01K), owned by EverEx, Inc., to examine safety and effectiveness in individuals with patellofemoral pain syndrome.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-02-07; most recent amendment 2025-01-21.
Status change: Recruiting → Active, Not Recruiting 2025-01-21
Status change: Not Yet Recruiting → Recruiting 2024-07-30
Trial Details
NCT Number NCT06260865
Lead Sponsor EverEx Inc.
Conditions Patellofemoral Pain Syndrome
Enrollment 216 participants
Start Date 2024-04-26
Primary Completion 2025-03-31 (estimated)
Study Completion 2025-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-23